Ella Platform – Medical Alley Association

Ella Platform

Bio-Techne and Cygnus Technologies Announce Partnership for 3G CHO-HCP Assay

MINNEAPOLIS and SOUTHPORT, August 13, 2019/PRNewswire/ — Bio-Techne Corporation and Cygnus Technologies, part of Maravai LifeSciences, announced today a strategic partnership for the quantification of Chinese hamster ovary host cell proteins (CHO-HCP) on the ProteinSimpleTM-branded EllaTM immunoassay platform. Under the terms of the agreement, Bio-Techne and Cygnus are introducing the co-developed third generation CHO-HCP assay […]

Uman Diagnostics and Bio-Techne Announce License and Supply Agreement for Neurofilament Light Assay

MINNEAPOLIS, July 23, 2019 /PRNewswire/ — Uman Diagnostics, now part of Quanterix, and Bio-Techne announced today a strategic License and Supply Agreement for the antibodies used in the quantification of neurofilament light (Nf-L) on the ProteinSimple™-branded Ella™ immunoassay platform. Under the terms of the agreement, Uman Diagnostics will supply Nf-L antibodies to Bio-Techne for use […]

Bio-Techne Releases 32×8 Cartridge for the Ella Platform

MINNEAPOLIS, July 17, 2019 /PRNewswire/ ‐‐ Bio‐Techne Corporation (NASDAQ: TECH) today announced the launch of a new 8‐Plex cartridge format for the ProteinSimple™‐branded Ella™ automated immunoassay platform. This new cartridge format analyzes 32 samples for eight distinct analytes, bringing higher multiplex capabilities to the Ella platform. The 32×8 cartridge for Ella enables users to build […]

Keep your finger on the pulse of Medical Alley from anywhere with the ALLEY NEWSLETTER